Cathelicidin LL-37 in Health and Diseases of the Oral Cavity

被引:27
|
作者
Tokajuk, Joanna [1 ,2 ]
Deptula, Piotr [1 ]
Piktel, Ewelina [3 ]
Daniluk, Tamara [1 ]
Chmielewska, Sylwia [1 ]
Wollny, Tomasz [4 ]
Wolak, Przemyslaw [5 ]
Fiedoruk, Krzysztof [1 ]
Bucki, Robert [1 ]
机构
[1] Med Univ Bialystok, Dept Med Microbiol & Nanobiomed Engn, Mickiewicza 2C, PL-15222 Bialystok, Poland
[2] Dent & Med Tokajuk, Zelazna 9-7, PL-15297 Bialystok, Poland
[3] Med Univ Bialystok, Independent Lab Nanomed, Mickiewicza 2B, PL-15222 Bialystok, Poland
[4] Holy Cross Oncol Ctr Kielce, Artwinskiego 3, PL-25734 Kielce, Poland
[5] Jan Kochanowski Univ Kielce, Coll Med, Inst Med Sci, IX Wiekow Kielc 19A, PL-25317 Kielce, Poland
关键词
oarl cavity; human cathelicidin; antimicrobial peptides; immunomodulation; ANTIMICROBIAL PEPTIDE LL-37; GINGIVAL CREVICULAR FLUID; PORPHYROMONAS-GINGIVALIS; ANTIBACTERIAL ACTIVITY; GROWTH-FACTOR; SALIVARY CONCENTRATION; EPITHELIAL-CELLS; INNATE IMMUNITY; MYELOID CELLS; CANCER-CELLS;
D O I
10.3390/biomedicines10051086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interaction might lead to the development of various oral pathologies and systemic diseases. Two important players in maintaining oral health or developing oral pathology are the oral microbiota and various immune molecules that are involved in controlling its quantitative and qualitative composition. The LL-37 peptide is an important molecule that upon release from human cathelicidin (hCAP-18) can directly perform antimicrobial action after insertion into surface structures of microorganisms and immunomodulatory function as an agonist of different cell membrane receptors. Oral LL-37 expression is an important factor in oral homeostasis that maintains the physiological microbiota but is also involved in the development of oral dysbiosis, infectious diseases (including viral, bacterial, and fungal infections), autoimmune diseases, and oral carcinomas. This peptide has also been proposed as a marker of inflammation severity and treatment outcome.
引用
收藏
页数:30
相关论文
共 50 条
  • [41] The human cathelicidin hCAP18/LL-37: A multifunctional peptide involved in mycobacterial infections
    Mendez-Samperio, Patricia
    PEPTIDES, 2010, 31 (09) : 1791 - 1798
  • [42] The Human Cathelicidin, LL-37, Induces Granzyme-mediated Apoptosis in Regulatory T Cells
    Mader, Jamie S.
    Ewen, Catherine
    Hancock, Robert E. W.
    Bleackley, Robert C.
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (03) : 229 - 235
  • [43] Between good and evil: Complexation of the human cathelicidin LL-37 with nucleic acids
    Zielke, Claudia
    Nielsen, Josefine Eilso
    Lin, Jennifer S.
    Barron, Annelise E.
    BIOPHYSICAL JOURNAL, 2024, 123 (11) : 1316 - 1328
  • [44] Effect of antimicrobial peptides derived from human cathelicidin LL-37 on Entamoeba histolytica trophozoites
    Rico-Mata, Rosa
    De Leon-Rodriguez, Luis M.
    Avila, Eva E.
    EXPERIMENTAL PARASITOLOGY, 2013, 133 (03) : 300 - 306
  • [45] The Human Cathelicidin LL-37 Preferentially Promotes Apoptosis of Infected Airway Epithelium
    Barlow, Peter G.
    Beaumont, Paula E.
    Cosseau, Celine
    Mackellar, Annie
    Wilkinson, Thomas S.
    Hancock, Robert E. W.
    Haslett, Chris
    Govan, John R. W.
    Simpson, A. John
    Davidson, Donald J.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2010, 43 (06) : 692 - 702
  • [46] The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung
    Tjabringa, GS
    Rabe, KF
    Hiemstra, PS
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2005, 18 (05) : 321 - 327
  • [47] The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections
    Babikir, Ibrahim H.
    Abugroun, Elsir A.
    Bilal, Naser Eldin
    Alghasham, Abdullah Ali
    Abdalla, Elmuataz Elmansi
    Adam, Ishag
    BMC INFECTIOUS DISEASES, 2018, 18
  • [48] Human Cathelicidin Peptide LL-37 Modulates the Effects of IFN-γ on APCs
    Nijnik, Anastasia
    Pistolic, Jelena
    Wyatt, Aaron
    Tam, Sheena
    Hancock, Robert E. W.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (09): : 5788 - 5798
  • [49] CATHELICIDIN LL-37 IN BRONCHOALVEOLAR LAVAGE AND EPITHELIAL LINING FLUIDS FROM COPD PATIENTS AND HEALTHY INDIVIDUALS
    Golec, M.
    Reichel, C.
    Lemieszek, M.
    Mackiewicz, B.
    Buczkowski, J.
    Sitkowska, J.
    Skorska, C.
    Dutkiewicz, J.
    Milanowski, J.
    Ziesche, R.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2012, 26 (04): : 617 - 625
  • [50] Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites
    Durnas, Bonita
    Wnorowska, Urszula
    Pogoda, Katarzyna
    Deptula, Piotr
    Watek, Marzena
    Piktel, Ewelina
    Gluszek, Stanislaw
    Gu, Xiaobo
    Savage, Paul B.
    Niemirowicz, Katarzyna
    Bucki, Robert
    PLOS ONE, 2016, 11 (06):